Correlation Between Nascent Biotech and Protokinetix

Can any of the company-specific risk be diversified away by investing in both Nascent Biotech and Protokinetix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nascent Biotech and Protokinetix into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nascent Biotech and Protokinetix, you can compare the effects of market volatilities on Nascent Biotech and Protokinetix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nascent Biotech with a short position of Protokinetix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nascent Biotech and Protokinetix.

Diversification Opportunities for Nascent Biotech and Protokinetix

-0.44

Correlation Coefficient

Nascent Biotech  Protokinetix

Very good diversification

The 3 months correlation between Nascent and Protokinetix is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Nascent Biotech and Protokinetix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protokinetix and Nascent Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nascent Biotech are associated (or correlated) with Protokinetix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protokinetix has no effect on the direction of Nascent Biotech i.e., Nascent Biotech and Protokinetix go up and down completely randomly.

Pair Corralation between Nascent Biotech and Protokinetix

Given the investment horizon of 90 days Nascent Biotech is expected to generate 0.81 times more return on investment than Protokinetix. However, Nascent Biotech is 1.24 times less risky than Protokinetix. It trades about 0.09 of its potential returns per unit of risk. Protokinetix is currently generating about 0.02 per unit of risk. If you would invest  4.60  in Nascent Biotech on September 3, 2024 and sell it today you would earn a total of  1.58  from holding Nascent Biotech or generate 34.35% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	98.46%
Values	Daily Returns

Nascent Biotech  vs.  Protokinetix

Nascent Biotech

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Nascent Biotech are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Nascent Biotech displayed solid returns over the last few months and may actually be approaching a breakup point.

Protokinetix

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Protokinetix are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Protokinetix showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Nascent Biotech and Protokinetix

The main advantage of trading using opposite Nascent Biotech and Protokinetix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nascent Biotech position performs unexpectedly, Protokinetix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protokinetix will offset losses from the drop in Protokinetix's long position.

The idea behind Nascent Biotech and Protokinetix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .